Cangrelor for heart attack patients on heart-lung support
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests whether adding a fast-acting anti-clotting drug (cangrelor) helps people having a massive heart attack who need a heart-lung machine (VA-ECMO). The goal is to see if it reduces clotting risks without causing dangerous bleeding.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a massive heart attack with a shock or cardiac arrest that required a heart-lung machine (VA-ECMO).
- You need or have had a procedure to open blocked heart arteries (PCI).
- You have not taken any oral P2Y12 anti-clotting pills (like clopidogrel, prasugrel, or ticagrelor).
- You have not had a stroke or mini-stroke (TIA).
- You have no active, uncontrollable bleeding or suspected brain bleed.
- You are not pregnant and have no allergy to cangrelor.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether using a life-support machine called ECMO (extra support for the heart and lungs) helps people who develop shock right after a heart attack. It aims to improve outcomes when blood flow is failing and organs may be struggling.
This study looks at the best way to reopen blocked heart arteries (using a stent procedure) in people who had a heart attack complicated by severe shock and need a life-support machine called VA-ECMO. It may help improve outcomes by testing which revascularization approach works best for multi-vessel blockages.
This trial tests if cangrelor, a fast-acting blood thinner, can prevent small vessel damage during a planned stent placement in patients with stable chest pain. It may help improve blood flow to the heart muscle.
This trial tests whether a blood-thinner drug called cangrelor helps patients who are having a special type of bypass surgery that uses a small incision instead of opening the whole chest. The surgery connects a healthy artery from your chest wall directly to a blocked heart vessel to restore blood flow.
This study tests a blood-thinning medicine called cangrelor for people with a rare complication where heparin causes a dangerous drop in platelets. It may help make heart surgery safer for those who cannot use heparin.
This study looks at how well a certain blood thinner (cangrelor) works when used as a 'bridge' before surgery or another procedure. It is for people who already need to be on this medicine for a short time.
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.